Starbucks Corporation (NASDAQ: SBUX) and Green Mountain Coffee Roasters, Inc. (NASDAQ:GMCR) today announced a strategic relationship for the manufacturing, marketing, distribution and sale of Starbucks® and Tazo® tea branded K-Cup® portion packs for use in GMCR’s Keurig® Single-Cup brewing system. The new relationship will provide owners of Keurig Single-Cup Brewers with the additional choice afforded by having Starbucks branded super-premium coffees available for their brewers. GMCR closed at $61.71, up 41.4%, on 42,205,281 traded shares.

BIOLASE Technology, Inc. (NASDAQ: BLTI) today reported unaudited operating results for its fourth quarter and year ended December 31, 2010. Net revenue for the 2010 fourth quarter was $9.7 million, up 56 percent sequentially from $6.2 million in the 2010 third quarter and down approximately seven percent from $10.4 million in the same quarter for 2009. The majority of sales in the 2010 fourth quarter were from the sale of the Company’s previous flagship Waterlase MD Turbo™ laser. The stock closed at $4.63, up 16.0%, on 2,493,169 traded shares.

Spectrum Pharmaceuticals (NASDAQ: SPPI) today reported financial results for the three and 12-months ended December 31, 2010. Consolidated revenue of $34 million was comprised of product sales of $31 million ($8 million from ZEVALIN, $23 million from FUSILEV) and $3 million from licensing fees. This represents a more than three-fold increase over the $9 million in consolidated revenue in the fourth quarter of 2009, which was comprised of $5 million from product sales. The stock closed at $7.58, up 9.90%, on 4,043,205 traded shares.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future

Accuray (NASDAQ: ARAY) and TomoTherapy Inc. (NASDAQ: TOMO) today announced that they have signed a definitive agreement under which Accuray will acquire TomoTherapy for $4.80 per share in cash and stock, or a total of approximately $277 million. The transaction combines the best-in-class technologies from two high-growth companies to create the premier radiation oncology company. he companies currently serve complementary patient populations that are treated by the same medical specialty. TOMO closed at $4.57, up 24.52%, on 19,052,063 traded shares.

James River Coal Company (NASDAQ: JRCC) today announced that it had net income of $78.2 million or $2.82 per fully diluted share for the year ended December 31, 2010 and net income of $25.9 million or $0.93 per fully diluted share for the fourth quarter of 2010. Peter T. Socha, Chairman and Chief Executive Officer, commented: “We have invested in our Company during the downturn, and are looking forward to seeing the benefit of these investments during the months and years to come.” The stock closed at $23.21, up 14.6%, on 6,239,266 traded shares.

Dehaier Medical Systems Ltd. (NASDAQ: DHRM) today announced its financial results for the fourth quarter and 12 months ended December 31, 2010. Revenue increased by 126% year-over-year to $6.7 million, up from $2.9 million in the fourth quarter of 2009. Net income attributable to the Company improved 145% to $1.5 million, or $0.32 per diluted share, compared with net income of $602,000, or $0.20 per diluted share in the fourth quarter of 2009. The stock closed at $6.18, up 12.36%, on 77,142 traded shares.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future

Global Defense Technology & Systems, Inc. (NASDAQ: GTEC) today announced it has entered into a definitive agreement to be acquired through a cash tender offer at $24.25 per share by an affiliate of Ares Management LLC, in a transaction with a total value of approximately $315 million, including the assumption of debt and prior to expenses. Under the terms of the agreement, which was approved by GTEC’s Board of Directors, the tender offer is not subject to any financing contingencies.

America Service Group Inc. (NASDAQ: ASGR) and Valitás Health Services, Inc. announced today the signing of an agreement and plan of merger under which the two companies would be combined, bringing together two leading companies in the correctional healthcare field – America Service Group’s PHS Correctional Healthcare and Valitás’ Correctional Medical Services. Upon completion of the transaction, the combined company will have approximately 11,000 employees and independent contractors and will serve more than 400 correctional facilities.

USA Technologies, Inc. (NASDAQ: USAT) today announced that for the month of February 2011, the Company processed a record 6.4 million small-ticket transactions representing $10.3 million—a 24% increase in monthly dollars processed compared to September 2010 when the company last announced these figures, and a new milestone for the Company. The current monthly processing rate equates to over $120 million in annualized transactions, up 20% from the $100 million annualized transaction rate achieved in September 2010.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future

Amerigon Inc. (NASDAQ: ARGN) today announced that it had entered into a purchase agreement with shareholders representing 75.6 percent of the voting shares of W.E.T. Automotive Systems (W.E.T.), a publicly-traded German company located in Odelzhausen, Germany. Under the terms of the agreement, Amerigon would purchase all of the shares held by such shareholders at a price of euro 40 per share (or $55 per share at a euro/$1.37 exchange rate). The stock closed at $13.64, up 17.79%, on 2,743,439 volume.

Cimatron Limited (NASDAQ: CIMT) today announced that the Tel-Aviv Stock Exchange (”TASE”) has approved the dual listing of Cimatron’s ordinary shares on the TASE beginning when trading commences on Wednesday, March 2, 2011, under the ticker symbol CIMT. Cimatron’s ordinary shares will continue to be listed on the NASDAQ Capital Market in the United States, and Cimatron will remain subject to the rules and regulations of NASDAQ and of the U.S. Securities and Exchange Commission. The stock closed at $4.64, up 12.90%, on 140,717 volume.

NeoStem, Inc. (NYSE AMEX: NBS) announced today that Dr. Manny Alvarez, an esteemed Obstetrician and Gynecologist and recognized television and online healthcare professional, will become the spokesperson and public representative of NeoStem’s adult stem cell banking and cord blood banking programs. These services have been bundled together as a multi-generational stem cell collection and storage service that the Company will call the “Family Plan”. The stock closed at $1.40, up 9.38%, on 336,892 volume.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future

3D Systems Corp. (NASDAQ: TDSC) announced today that it earned 40 cents per share, fully diluted, for the fourth quarter of 2010 on a 42% revenue increase and a 400 basis point gross profit margin expansion compared to the fourth quarter of 2009. The company’s quarterly and annual earnings per share benefitted by 5 cents per share from releasing a portion of its valuation allowance on deferred tax assets. The stock closed at $49.36, up 40.43%, on 974,813 volume.

Hardinge Inc. (NASDAQ: HDNG) today announced results for its fourth quarter ended December 31, 2010. The Company reported net income of $1.9 million, or $0.17 per basic and diluted share for the fourth quarter, compared with a net loss of ($8.3) million, or ($0.73) per basic and diluted share for the same period of 2009. EBITDA was $4.9 million for fourth quarter 2010, improved from a loss of ($4.4) million in the fourth quarter 2009. The stock closed at $11.55, up 26.41%, on 379,789 volume.

Monotype Imaging Holdings Inc. (NASDAQ: TYPE) today announced financial results for the fourth quarter and full year ended Dec. 31, 2010. Fourth quarter revenue was $29.4 million, a 17 percent increase year-over-year. Full year 2010 revenue was $106.7 million, an increase of 13 percent year-over-year. Non-GAAP net adjusted EBITDA for the fourth quarter was $13.8 million, or 47 percent of revenue. Full year 2010 non-GAAP net adjusted EBITDA was $47.8 million, or 45 percent of revenue. The stock closed at $13.59, up 17.26%, on 489,051 volume.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future.

Threshold Pharmaceuticals, Inc. (NASDAQ: THLD) today announced that the Company reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 randomized trial of TH-302 in patients with soft tissue sarcoma. This pivotal trial is expected to begin in the middle of 2011, and will enroll patients with metastatic or locally advanced unresectable soft tissue sarcoma who have not previously received chemotherapy outside the adjuvant or neoadjuvant setting. The stock closed at $2.75, up 57.14%, on 8,208,773 volume.

Cyanotech Corporation (NASDAQ: CYAN) announced today that researchers at the University of California at Davis have determined that microalgae-based Hawaiian Spirulina Pacifica® may improve immune function and ameliorate anemia in persons over 50. Results of the UC Davis study will be published in the March edition of the journal Cellular & Molecular Immunology, in a paper entitled, ”The effects of Spirulina on anemia and immune function in senior citizens.” The stock closed at $3.65, up 39.31%, on 973,829 volume.

Syneron Medical Ltd. (NASDAQ: ELOS) today announced fourth quarter 2010 financial results for the three month period ended December 31, 2010. Fourth quarter 2010 revenue was $53.5 million, an increase of 14.7% compared to $46.6 million in the fourth quarter 2009. Fourth quarter 2010 income from continuing operations before non-controlling interest was $3.4 million, compared to a loss of $4.1 million in the fourth quarter 2009. The stock closed at $14.10, up 20.72%, on 1,870,387 volume.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future.

China Technology Development Group Corporation (NASDAQ: CTDC) announced today that the Board of Directors has appointed Mr. Liao Lin-Hsiang as the Chief Operating Officer and Mr. Bruno Diaz Herrera as Chief Technology Officer of the Company effective from December 13, 2010. Mr. Liao Lin-Hsiang, the Chief Operating Officer, will be responsible for operation management of the Company and its subsidiaries. Mr. Bruno Diaz Herrera, the Chief Technology Officer, will be responsible for the technology management, product development and R&D strategy. The stock closed at $2.49, up 18.00%, on 434,310 traded shares.

Ramius V&O Acquisition LLC, a subsidiary of Ramius LLC, today announced that Cypress Bioscience, Inc. (NASDAQ: CYPB) has rejected its fully financed offer to acquire all of Cypress’ outstanding Common Stock in a negotiated transaction for $6.00 per share in cash. In light of the foregoing, Ramius intends to promptly amend its current tender offer to increase the offer price to $6.00 per share in cash and, among other things, to eliminate the financing condition. Ramius currently owns 9.9% of Cypress and commenced a tender offer on September 15, 2010 to purchase all of the shares of Cypress it does not currently own for $4.25 per share. The stock closed at $5.75, up 20.04%, on 4,792,945 traded shares.

FSI International, Inc. (NASDAQ: FSII) announced today the receipt of an order for its FSI ORION® single wafer cleaning platform from a major Asian semiconductor manufacturer. The order represents acceptance of the evaluation tool shipped in late 2009 for front-end-of-line (FEOL) development programs. This system is now qualified in ashless all-wet photoresist strip and silicon etch for the production of 28nm logic devices. Revenues for the four-chamber evaluation system and four-chamber expansion model is expected to be recognized in the second quarter of fiscal 2011. The stock closed at $4.63, up 10.50%, on 1,444,239 traded shares.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future

Conn’s, Inc. (NASDAQ: CONN) today announced its operating results for the quarter ended October 31, 2010. Retail gross margin increased to 25.2% for the quarter, as compared to 22.4% for the same period in the prior fiscal year. Retail segment loss before income taxes was $2.2 million for the quarter, as compared to a loss of $19.2 million for the same quarter in the prior fiscal year. The prior year loss included a goodwill impairment charge of $9.6 million and a $4.1 million litigation reserve adjustment. The stock closed at $4.46, up 38.08%, on 1,285,143 traded shares.

Zogenix, Inc. (NASDAQ: ZGNX) and Desitin Pharmaceuticals GmbH today announced that the Danish Medicines Agency of Denmark has approved the Marketing Authorization Application (MAA) for SUMAVEL® DosePro™ (sumatriptan injection) Needle-Free Delivery System. Denmark is the first country in Europe to grant marketing authorization for SUMAVEL DosePro for the acute treatment of migraine attacks, with or without aura, and the acute treatment of cluster headache. The stock closed at $4.64, up 16.00%, on 311,403 traded shares.

Longwei Petroleum Investment Holding Ltd. (NYSE AMEX: LPH) today announced annual contracts with two new customers for its Gujiao petroleum storage facility representing sales of 19,000 metric tons of petroleum products. The Company estimates that the contracts will be worth approximately $20.1 million based on current pricing levels. Mr. Cai Yongjun, Chairman and CEO of Longwei, stated, "We are on track with our plan and expect continued strong operating results for our current fiscal year.” The stock closed at $2.79, up 7.31%, on 699,474 traded shares.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future

Astrotech Corporation (NASDAQ: ASTC) today announced that its Astrotech Space Operations subsidiary has won a fully-funded task order under the $35 million Vandenberg Air Force Base (VAFB) indefinite delivery, indefinite quantity (IDIQ) contract. The Company will provide facilities and payload processing services from its VAFB location in support of NASA’s National Polar-orbiting Operational Environmental Satellite System (NPOESS) Preparatory Project (NPP) mission scheduled to launch October 25, 2011. The stock closed at $1.47, up 45.54%, on 5,246,346 traded shares.

Uranerz Energy Corporation (NYSE AMEX: URZ) is pleased to announce that the United States Nuclear Regulatory Commission (”NRC”) has issued in draft form the Materials License Number SUA-1597 to the Company on its Nichols Ranch In-Situ Recovery (”ISR”) Project located in Campbell and Johnson Counties, Wyoming, U.S.A. The draft Materials License is a fundamental step in obtaining the final NRC Materials License that, along with the State of Wyoming Permit To Mine, currently in the final stages of approval, will allow the Company to develop its first ISR uranium mine in Wyoming. The stock closed at $3.57, up 11.91%, on 3,033,845 traded shares.

The LGL Group, Inc. (NYSE AMEX: LGL) told stockholders that it enters 2011 with strong customer and technology positions, and its key market segments, which include Telecommunications Infrastructure and Military, Instrumentation, Space and Avionics (”MISA”) Communications, are forecasting growth. In addition, the Company noted that its balance sheet is “significantly improved.” CEO Greg Anderson also highlighted the Company’s current new product design efforts, specifically mentioning development of small format ASIC-based timing devices for very precise timing applications. The stock closed at $20.50, up 9.16%, on 45,419 traded sharse.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future

Apricus Biosciences, Inc. (NASDAQ: APRI) today announced that it has filed the protocol for a proposed Phase 3 clinical trial of PrevOnco™, its proprietary treatment for hepatocellular carcinoma (liver cancer), with the U.S. Food and Drug Administration (FDA). The FDA will review the protocol under its Special Protocol Assessment (SPA) program, under which the FDA would give approval for the trial’s design, clinical endpoints and statistical analysis. The Phase 3 study is expected to take about 12-24 months depending on the recruitment of patients. The stock closed at $3.35, up 24.07%, on 7,622,966 traded shares.

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Bayer HealthCare today announced that in two parallel Phase 3 studies in patients with the neovascular form of age-related macular degeneration (wet AMD), all regimens of VEGF Trap-Eye (aflibercept ophthalmic solution), including VEGF Trap-Eye dosed every two months, successfully met the primary endpoint compared to the current standard of care, ranibizumab dosed every month. The primary endpoint was statistical non-inferiority in the proportion of patients who maintained (or improved) vision over 52 weeks compared to ranibizumab. The stock closed at $29.53, up 19.70%, on 5,265,479 traded shares.

Citi Trends, Inc. (NASDAQ: CTRN) today reported results for the third quarter of fiscal 2010. Total sales in the third quarter ended October 30, 2010 increased 10.0% to $140.0 million compared with $127.4 million in the third quarter ended October 31, 2009. Comparable store sales decreased 4.2% in the third quarter. A net loss of $394,000 was recognized in this year’s third quarter compared with net income of $606,000 in the third quarter of 2009. The stock closed at $24.31, up 642,798 traded shares.

About QualityStocks:

QualityStocks, based in Scottsdale, Arizona is a free service that collects data from hundreds Small-Cap and Micro-Cap online Investment Newsletters into one Free Daily Newsletter Report. Our name emphasizes the commitment we have to connect subscribers with companies that have huge potential to succeed in the short and long-term future